These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9694031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S, Chiang TJ, Mobini S, Ho MY, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2001 Nov 27; 158(3):305-13. PubMed ID: 11713621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM, Chang YH.
    Proc Natl Sci Counc Repub China B; 2001 Oct 27; 25(4):223-32. PubMed ID: 11699570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 27; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ, Coscina DV, Fletcher PJ.
    Brain Res; 1998 Jul 27; 800(1):62-8. PubMed ID: 9685586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.
    Nakamura K, Kurasawa M.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 27; 361(5):521-8. PubMed ID: 10832606
    [Abstract] [Full Text] [Related]

  • 20. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H, Velázquez-Martínez DN.
    J Psychopharmacol; 2001 Mar 27; 15(1):29-36. PubMed ID: 11277605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.